This site is intended for us health care professionals only. For the safe and proper use of the devices referenced within, refer to the complete instructions for use or the appropriate manual. Zerbaxa fda prescribing information, side effects and uses. Is thought to be better than ceftazidimeavibactam for multidrugresistant pseudomonas aeruginiosa, because ceftolozanetaezobactams structure allows for greater bacterial. Zerbaxa ceftolozanetazobactam for injection package insert. Cephalosporin that has demonstrated potent in vitro activity against pseudomonas aeruginosa.
Zerbaxa ceftolozane tazobactam for injection, for intravenous use. Description azactam aztreonam injection contains the active ingredient aztreonam, a monobactam. Zerbaxa, a combination of ceftolozane and tazobactam, is used for enterobacteriaceae and pseudomonas aeruginosa infections. Aseptically transfer the required dose of reconstituted dalbavancin solution. Zerbaxa may also be used for purposes not listed in this medication guide. New antibiotic options are needed for the treatment of multidrugresistant mdr pseudomonas infections. Ceftolozanetazobactam mic test strip technical sheet introduction lio. Zerbaxa is a combination antibiotic that is used to treat certain bacterial infections of the lungs, stomach, or urinary tract. Hu y, turner mj, shields j, gale ms, hutto e, roberts bl, et al.
Highlights of prescribing information zinplavasafely and. Zerbaxa ceftolozane and tazobactam is a combination of ceftolozane, a cephalosporin antibacterial, and tazobactam, a betalactamase inhibitor, indicated in patients 18 years or older for the treatment of the following infections caused by designated susceptible microorganisms. Zerbaxa s approval was the 4th antibiotic approved by the fda in 2014, after a long dry spell during which many pharmaceutical companies had largely abandoned the antibiotics market. Ceftolozanetazobactam zerbaxa national drug monograph. Decreased efficacy of zerbaxa has been observed in patients with baseline crcl of 30 to. Please also see full prescribing information for azactam. Zerbaxa solution may be held for 1 hour prior to transfer and dilution in a suitable infusion bag. Etest strips must be kept dry with active desiccant. It is active against methicillinresistant staphylococcus aureus mrsa and grampositive bacteria.
Zerbaxa, innceftolozanetazobactam european medicines agency. Complicated intraabdominal infections zerbaxa used in combination with metronidazole is indicated for the treatment of complicated intraabdominal infections. Ceftolozanetazobactam mic test strip technical sheet. The recommended dosage regimen of zerbaxa for injection is 1. Supplementary inserts specific to each antimicrobial are also available. Pseudomonas aeruginosa is a common cause of healthcareassociated pneumonia and ventilatorassociated pneumonia. Successful treatment of multidrugresistant pseudomonas. The pharmacokinetic and safety profiles of this antibiotic have been established in healthy adults and subjects with various degrees of renal function 1, 2. Etest is a quantitative technique for determining the antimicrobial susceptibility of gramnegative and grampositive aerobic bacteria such. Ceftolozane belongs to the cephalosporin class of antibacterial drugs. Etest is supplied in a package of 30 or 100 test strips depending on package format of one antimicrobial agent. Oct 16, 2017 like avibactam and tazobactam, vaborbactam protects its betalactam from degradation by enzymes produced by multidrugresistant gram negative bacteria. The prescribing information for ceftolozanetazobactam warns of possible allergic.
Ceftaroline is a cephalosporin within vitroactivity against grampositive and negative bacteria. Zerbaxa for injection is indicated for the treatment of patients 18 years or older with the following infections caused by designated susceptible microorganisms. Highlights of prescribing information these highlights do not include all the information needed to use emgality safely and effectively. Ceftolozanetazobactam was approved by the food and drug administration fda on. Highlights of prescribing information zerbaxa 750 mg 250. Zerbaxa is being prescribed for the treatment of complicated urinary tract infections cuti, including pyelonephritis, caused by the following gramnegative microorganisms. The reality is people are dying of multidrugresistant pathogens, particularly gramnegative bacilli. Ceftolozanetazobactam therapy of respiratory infections due. Bumetanide is a loop diuretic, available in 4 ml and 10 ml vials for intravenous or intramuscular injection as a sterile solution.
Merck was found to be noninferior to meropenem in the treatment of adult patients with either ventilated hospitalacquired bacterial pneumonia habp or. Minibag plus systems, viaflex containers and vialmate adaptor devices are rx only. The package insert states decreased efficacy seen in patients with a baseline creatinine clearance 50 mlmin had a clinical cure rate of 85. The infectious diseases society of america idsa voiced its happiness at zerbaxa s approval in a press release, saying. Repeated antibiotic courses, without correcting the fistula, resulted in infection with mdr pseudomonas aeruginosa. The package insert states decreased efficacy seen in patients with a baseline creatinine clearance zerbaxa is indicated for the treatment of patients 18 years and older with hospitalacquired bacterial pneumonia and ventilatorassociated bacterial pneumonia habpvabp, caused by the following susceptible gramnegative microorganisms. Patients are calculated based on an estimated annual cumulative dose. Prevent moisture from penetrating into or forming within the package or storage container. Reconstituted vials may be stored either refrigerated at 2 to 8 c 36 to 46 f, or at controlled room temperature 20 to 25 c 68 to 77 f.
Zerbaxa ceftolozanetazobactam is an antibacterial drug product composed of a cephalosporin and a beta lactamase inhibitor. Positive results for zerbaxa in phase 3 study of ventilated. To the editor ceftolozanetazobactam ct has recently been approved in the united states for the treatment of complicated urinary tract infections and, in conjunction with metronidazole, for intraabdominal infections. Zerbaxa ceftolozanetazobactam dose, indications, adverse. Indicated for treatment of hospitalacquired bacterial pneumonia and ventilatorassociated bacterial pneumonia habp. Merck was found to be noninferior to meropenem in the treatment of adult patients with either ventilated. Selected safety information patients with renal impairment. Jun 03, 2019 zerbaxa ceftolozane and tazobactam is a combination of ceftolozane, a cephalosporin antibacterial, and tazobactam, a betalactamase inhibitor, indicated in patients 18 years or older for the treatment of the following infections caused by designated susceptible microorganisms. Zerbaxa was evaluated in phase3 comparatorcontrolled clinical trials of complicated intraabdominal infections and complicated urinary tract infections including pyelonephritis, which included a total of 1,015patients, treated with zerbaxa 1g0. Aseptically transfer the required dose of reconstituted dalbavancin solution from the vials to an intravenous bag or bottle containing 5% dextrose injection, usp. We recently successfully used ct in the treatment of 3 patients with pneumonia due to mdr p. The package insert states decreased efficacy seen in patients with a baseline creatinine clearance escherichia coli, haemophilus influenzae, klebsiella oxytoca, klebsiella pneumoniae, proteus mirabilis, pseudomonas aeruginosa. Infusion to reduce the development of drugresistant bacteria and maintain the effectiveness of.
It is indicated for the treatment of adult patients with complicated urinary tract infections cuti including acute pyelonephritis, and in combination with metronidazole, complicated intraabdominal infections ciai. Dec 26, 2019 bumetanide is a loop diuretic, available in 4 ml and 10 ml vials for intravenous or intramuscular injection as a sterile solution. Do not use the etest gradient strips if the package has been damaged. Zosyn is a monosodium salt of piperacillin and a monosodium salt of tazobactam containing a. It retains the activity of latergeneration cephalosporins having broadspectrum activity against gramnegative bacteria. Follow all directions on your medicine label and package. Ceftolozane has been proven to have greater affinity for pbps when compared with ceftazidime and imipenem. Ceftolozanetazobactam zerbaxa, merck september 2015. We present a case of a man aged 64 years with a bladder fistula due to radiation, ultimately causing osteomyelitis of the pubic symphysis. Each vial contains 50 mg of amphotericin b, usp, intercalated into a liposomal membrane consisting of approximately 0. The diluted solution must have a final dalbavancin concentration of 1 mgml to 5 mgml. Zerbaxa does not contain a bacteriostatic preservative.
Ceftolozanetazobactam therapy of respiratory infections. What drugs, substances, or supplements interact with zerbaxa. Register to receive product and educational information from tetraphase, its affiliates, and service providers. Left ventricular dysfunction and embryofetal toxicity see full prescribing information for complete boxed warning. In a clinical trial, patients with ciais with crcl 50 mlmin had a clinical cure rate of 85. Dailymed zerbaxa ceftolozane and tazobactam injection. Full prescribing information 1 indications and usage zinplavais indicated to reduce recurrence of clostridium difficile infectioncdi in patients 18 years of age or older who are receiving antibacterial drug treatment of cdi and are at a high risk for cdi recurrence. Zerbaxa 750 mg 500 mg and 250 mg followed by a zerbaxa 150 mg 100 mg and 50 mg maintenance dose administered intravenously every 8 hours for the remainder of the treatment period on hemodialysis days, administer the dose at the earliest possible time following completion of dialysis a single loading dose of zerbaxa 2. Upon constitution with sterile water for injection or 0. Prescribing information register how to order medical inquiry. Aseptic technique must be followed in preparing the infusion solution.
The crisis of bad bugs, no drugs has led to the infectious diseases society of america 10 x 20 initiative, the national action plan for combating antibioticresistant bacteria, carbx, and other efforts to combat or call attention to drugresistant bacteria. Leftover mic test strip from an opened package must be stored at 28c in the airtight tube, containing desiccant, provided in the pack for no more than 7 days. This product information was approved at the time this auspar was published. Zerbaxa ceftolozane and tazobactam for injection, for intravenous use drug information pdf dosing. The in vitro spectrum of cts activity includes both susceptible and multidrugresistant mdr strains of pseudomonas aeruginosa. Compatible with standard 20 mm closure, singledose, powdereddrug vials. Emgality galcanezumabgnlm injection, for subcutaneous use initial u.
Of note, vaborbactam does not improve the effect of meropenem versus acinetobacter spp. Indicated for complicated urinary tract infections cuti, including pyelonephritis, caused by escherichia coli, klebsiella pneumoniae, proteus mirabilis, and pseudomonas aeruginosa. Highlights of prescribing information neulasta safely and. Ceftolozanetazobactam zerbaxa is the combination of cephalosporin ceftolozane plus betalactamase inhibitor tazobactam has activity versus pseudomonas aeruginosa is thought to be better than ceftazidimeavibactam for multidrugresistant pseudomonas aeruginiosa, because ceftolozanetaezobactams structure allows for greater bacterial membrane permeability and more.
Neulasta pegfilgrastiminjection,for subcutaneous use initial u. Perjeta can result in subclinical and clinical cardiac failure manifesting as decreased lvef and chf. Ceftolozanetazobactam zerbaxa is the combination of cephalosporin ceftolozane plus betalactamase inhibitor tazobactam. The bactericidal action of ceftolozane results from inhibition of cell wall.
Venofer is indicated for the treatment of iron deficiency anemia in patients. The recommended dose of zerbaxa in adult patients with habpvabp and creatinine clearance crcl greater than 50 mlmin is 3 grams two 1. It is a wellknown fact that we are in a crisis, and we are running out of time. Complicated urinary tract infections cuti, including pyelonephritis 1. Engerixb can be given on either dosing schedule 0, 1, and 6 months or 0, 1, 2, and 12 months. Dec 31, 2019 zerbaxa was evaluated in phase 3 comparatorcontrolled clinical trials of ciai and cuti, which included a total of 1015 patients treated with zerbaxa 1. Engerixb is indicated for immunization against infection.
Dosing for zerbaxa ceftolozane and tazobactam official site. Zerbaxa is sometimes given in combination with another antibiotic medicine. The recommended dosage of zerbaxa for injection is 1. Handling before using the etest gradient strips from an unopened package, visually inspect to ensure the package is intact. Investigation of the mechanism of action of alemtuzumab in a human cd52 transgenic mouse model. Complicated urinarytract infections may affect the lower urinary tract or upper urinary tract pyelonephritis. The reconstituted vial contains 20 mgml dalbavancin as a clear, colorless to yellow solution. Side effects of zerbaxa ceftolozane and tazobactam for. Ambisome amphotericin b liposome for injection description ambisome for injection is a sterile, nonpyrogenic lyophilized product for intravenous infusion. Vaborbactam also does not work against metallobetalactamases. Highlights of prescribing information see full prescribing. Enterobacter cloacae, escherichia coli, haemophilus influenzae, klebsiella oxytoca, klebsiella pneumoniae, proteus mirabilis, pseudomonas aeruginosa, and. It was originally isolated from chromobacterium violaceum.
Zerbaxa was evaluated in phase 3 comparatorcontrolled clinical trials of ciai and cuti, which included a total of 1015 patients treated with zerbaxa 1. Zinplava is not indicated for the treatment of cdi. Ceftolozanetazobactam pharmacokinetics in a critically. Ceftolozanetazobactam is a novel oxyiminoaminothiazolyl cephalosporin and. For the etest application guide, select guided search by reagents. Highlights of prescribing information zerbaxa 750 mg 250 mg.
672 792 332 251 114 1017 1360 829 397 999 257 1328 533 571 234 152 1462 314 594 935 304 149 1008 500 475 1450 184 256 436 1090 445 291 1107 155 953 150 501 677 578